How Long Can You Stay on Weight Loss Injections?

Mounjaro (tirzepatide) has no maximum treatment duration written into its UK product licence; ongoing use is guided by clinical review and evidence of continued benefit.
Wegovy (semaglutide injection) is recommended by NICE for a maximum of two years when prescribed through NHS specialist weight management services, though private prescribing follows the licensed SmPC rather than NICE's NHS commissioning rules.
Both medicines require regular prescriber re-assessment; treatment is not automatically renewed, and a dose that stops producing meaningful benefit is a reason to reassess.
Weight often returns when treatment stops, which is why the decision about how long to stay on weight loss injections is a clinical one, not a self-managed one.

Most adults can stay on weight loss injections for as long as they remain clinically suitable and continue to benefit from treatment. There is no fixed universal time limit written into the licences for Mounjaro or Wegovy, but your prescriber will review whether continuing makes sense at every stage. These are prescription-only medicines, and that clinical review is not a formality. The honest answer is: it depends on which medicine you're taking, what the evidence says, and what your individual circumstances look like.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence and regulators say about long-term use of weight loss injections

Is there a time limit on how long you can take these injections?

This is a question our prescribers hear most weeks, and the answer is more nuanced than many people expect. Mounjaro's UK product licence does not specify a maximum treatment duration. Clinical trials ran for 72 weeks and showed continued weight reduction throughout, but real-world prescribing can extend beyond that period, subject to ongoing review. If you're asking how long you can take weight loss injections without a fixed endpoint in mind, the short answer for tirzepatide is: there isn't one written into the licence.

Wegovy's position is slightly different in the NHS context. NICE's recommendation (TA875) specifies a maximum of two years when semaglutide is used within an NHS specialist weight management service. That two-year cap is part of the NHS commissioning guidance, not the medicine's licence itself. Private prescribing is governed by the SmPC, which does not impose the same ceiling. That distinction matters if you're weighing up your options, and the range of weight loss injections available in the UK each carry their own guidance on this.

In practice, how long you stay on either injection depends on three things: whether you're still losing weight or maintaining a meaningful reduction, whether side effects remain manageable, and whether your prescriber judges that the benefits outweigh any risks at each review. That assessment happens at every repeat order, not just at the start.

What happens to weight when you stop — and does that change how long people stay on treatment?

This is where the evidence gets important. Clinical trial data for both tirzepatide and semaglutide consistently shows that a significant proportion of lost weight returns when treatment is stopped. In STEP 1, participants who discontinued semaglutide regained most of the weight they had lost within a year. The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed a similar pattern in extension analyses.

This doesn't mean everyone needs to stay on injections indefinitely. Some people make lasting changes to how they eat and move during treatment, and those habits reduce regain risk. Others find that stopping prompts a rapid return of appetite and weight. Neither outcome is a moral failing; it reflects the biology of appetite regulation. Weight is shaped by hormones and physiology, not willpower alone.

Understanding this is part of why the question of how long to stay on weight loss injections should involve your prescriber directly. A plan to stop treatment gradually, with lifestyle support in place, produces better outcomes than an abrupt stop. And some people, after discussion with their clinician, decide that long-term or indefinite treatment is the right choice for them. That is a legitimate clinical decision, not a shortcut.

How does clinical review shape the decision over time?

Neither Mounjaro nor Wegovy is designed to be taken forever without reassessment. The NICE guidance for tirzepatide (TA1026) notes that if a person loses less than five percent of their body weight after six months at their highest tolerated dose, continuing should be reviewed. That threshold applies to NHS prescribing, but it reflects a sensible principle that applies privately too: if a medicine is not producing meaningful benefit, the case for continuing weakens.

At nume, every repeat order goes through a clinical review by a GPhC-registered prescriber — not an automated process. A real clinician looks at your progress before a further supply is issued. You can read more about how long you can be on weight loss injections and how reviews work in practice, or explore the wider landscape of weight loss treatment options if you're still deciding which route makes sense. For context on what treatment typically involves financially, the treatment page sets out what's included in each order.

The NHS page on tirzepatide also covers the practicalities of ongoing use in plain language, including what to discuss with your healthcare provider if your circumstances change.

Can you stay on weight loss injections for life?

Possibly, yes. There is no evidence that long-term use of licensed GLP-1 medicines at appropriate doses causes harm that would rule out extended treatment as a category. The question of whether staying on weight loss injections for life is realistic is one more people are now asking seriously, and clinicians are taking it seriously too, particularly as services like our weight loss injections clinic in Cardiff see growing numbers of patients considering exactly that conversation.

What the current evidence cannot tell us definitively is what happens over decades, because the longest trials have run for a few years. Ongoing post-marketing surveillance, including the MHRA's monitoring programmes, will add to that picture over time. For now, the position is: extended use is clinically supported where benefit continues and side effects are acceptable, and the decision is made with a prescriber, not unilaterally.

If you are thinking about long-term use and want to talk through your personal situation, the starting point is always a clinical consultation. Speak to our prescribers, and they will give you an honest view based on your health history rather than a one-size answer.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions